Company Filing History:
Years Active: 2020-2023
Title: The Innovations of Robin Butler
Introduction
Robin Butler is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic proteins and antibodies. With a total of 2 patents to his name, Butler's work has the potential to impact the treatment of various immune and inflammatory disorders.
Latest Patents
Butler's latest patents include innovations related to polynucleotides encoding IL-33 antibodies. The first patent provides isolated IL-33 proteins, active fragments thereof, and antibodies against IL-33 proteins. This invention also outlines methods for modulating cytokine activity, which can be crucial for treating immune and inflammatory disorders. The second patent similarly focuses on IL-33 proteins, including mutated forms and their corresponding antibodies, along with assays and methods for their application.
Career Highlights
Robin Butler is currently associated with Medimmune Limited, a company known for its focus on innovative biopharmaceuticals. His work at Medimmune has allowed him to explore and develop groundbreaking solutions in the field of immunology.
Collaborations
Throughout his career, Butler has collaborated with several talented individuals, including Emma Suzanne Cohen and David C Lowe. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Robin Butler's contributions to biotechnology through his patents on IL-33 proteins and antibodies highlight his innovative spirit and dedication to improving healthcare. His work continues to pave the way for new treatments for immune and inflammatory disorders.